(application has closed) 45th Breakfast Meeting
date : 8/30/2013

Normal 0 0 2 false false false EN-US JA X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:標準の表; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:””; mso-padding-alt:0mm 5.4pt 0mm 5.4pt; mso-para-margin:0mm; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.5pt; mso-bidi-font-size:11.0pt; font-family:”Century”,”serif”; mso-ascii-font-family:Century; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:Century; mso-hansi-theme-font:minor-latin; mso-font-kerning:1.0pt;}
In May 2013, as a result of how the Hollywood
actress Angelina Jolie had boldly shared her experience which she explained of
how and why she had underwent mastectomy to prevent the risk of developing
breast cancer in the future when she found that mutations in the BRCA1 gene
were detected in the genetic testing of hereditary breast ovarian cancer via
New York Times The Opinion Pages, the news had turned into a hot topic in
Japan.
At almost the same time, “New
prenatal diagnosis” was available for the pregnant women to determine the
presence of chromosomal abnormalities in fetal blood test in April this year. As
the genetic analysis technology advances, examining and predicting future disease
of the baby through fetal genetic testing is made possible. However, this has
also accompanied with difficult choices to make. Fear is also voiced as the
technology may lead to discrimination of people with possible diseases.
We have invited Chieko Tamura, the only person in Japan who holds both American and Japanese certificates as a genetic counselor to share with us the current situation and challenges of genetic counseling and genetic testing. Discussion time will be available in the second half of the session.
(medium: Japanese)
■Date and Time
Sep 19, 2013 8:00am-9:00am
■Venue
GARB Marunouchi (2-2-3 Marunouchi, Chiyoda-ku, Tokyo)■Theme
“Why did Angelina Jolie undergo the surgery? – a perspective of a certified genetic counselor from both Japan and the United States with regards to the current situation and challenges of genetic counseling and genetic testing.”
■Speaker
Chieko Tamura
Chieko Tamura originally studied
pharmaceutical science, and has a Japanese national license as a pharmacist,
since 1988. After working for a
pharmaceutical company for thirteen years as a basic and clinical research
scientist and a product manager, she went to the U.S.A. as a Fulbright scholar
and studied genetic counseling at the joint graduate program of the National
Human Genome Research Institute and Johns Hopkins University School of Public
Health, and graduated in 2003 getting the master’s degree. She has been certified as a genetic counselor
by the American Board of Genetic Counseling as well as the Japanese Board of
Genetic Counseling. She is currently the
only person who holds both American and Japanese certificates as a genetic
counselor, and is now a board member of the Japanese Association of Certified
Genetic Counselors. After returning to
Japan in 2003, she worked as a genetic counselor, at many different medical
institutions, including the Japan’s National Center for Child Health and
Development, several university hospitals and major fertility clinics, covering
a variety of conditions, including prenatal, pediatrics, adult genetics, cancer
genetics, neurogenetics, and infertility, etc.
Ms. Tamura also worked as an associate professor for five years at one
of the newly established genetic counseling training graduate programs at
Ochanomizu University in Tokyo. She has
been working as an advisor to several patient and family support groups, with
Marfan syndrome, Turner syndrome, prion diseases, familial colon cancer,
spinocerebellar ataxia, etc.
■Application Procedure
Please complete the online procedure on the Health and Global Policy Institute website by noon on Thursday, Sep 19th, 2013. When the seats are fully booked, we may stop accepting applications.
■Fee
Supporting Members: Free
(About Supporting Members: https://www.hgpi.org/en/donation.html)
General and Registered Members: 2,000 Yen
(About Registered Members: https://www.hgpi.org/en/mail.html)
Students: 500 Yen (Please show your school identification card.)Registration deadline: 2013-09-17
Exhibition date:2013-09-19
Top Research & Recommendations Posts
- [Policy Recommendation] Preparing for “Disaster-Level Heat” in the 2025 Basic Policy on Economic and Fiscal Management and Reform (June 9, 2025)
- [Policy Recommendation] Integrating “Planetary Health” as a Growth Strategy — Proposal for the Grand Design and Action Plan for a New Form of Capitalism (2025 Revised Edition) (June 9, 2025)
- [Event Report] Round Table Discussion “Understanding Menopausal Women’s Health as a Social Issue” (November 19, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] Survey of Japanese Nursing Professionals Regarding Climate Change and Health (Final Version) (November 14, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Policy Recommendations] HGPI Joint Input to the Zero Draft Political Declaration on NCDs and Mental Health (May 23, 2025)
- [Policy Recommendations] Achieving a Sustainable Society of Health and Longevity Through the Integration of Environment and Healthcare-Incorporating a Planetary Health Perspective into the 3rd Phase of The Healthcare Policy-(December 20, 2024)
Featured Posts
-
2025-07-04
[Registration Open] (Webinar) The 136th HGPI Seminar “Where We Are Now and Where We Are Going Regarding PPI in Mental Health Research: Learning from the TOGETHER Project in the Form of Co-Creation” (July 28, 2025)
-
2025-07-04
[Event Report] The HGPI Cardiovascular Disease (CVD) Control Promotion Project Online Global Symposium “Exploring the Future of CVD Control Through Policy Case Studies in the Asia-Pacific Region” (March 13, 2025)
-
2025-07-04
[HGPI Policy Column] (No. 62) From the Dementia Project “The Current State of Dementia Policy in the International Community in 2025”
-
2025-07-04
[Recommendations] HGPI Expert Policy Advocacy Platform “Better Use of Cost-effectiveness Evaluation for Pharmaceuticals in Japan” (May 7, 2025)